Zobrazeno 1 - 10
of 84
pro vyhledávání: '"Guangxin, Zhou"'
Publikováno v:
BMC Public Health, Vol 24, Iss 1, Pp 1-15 (2024)
Abstract Background This study aims to explore the development status of the supply level of professional public health resources in Beijing Municipality, analyze the areal differences and spatial distribution characteristics of the supply level in 1
Externí odkaz:
https://doaj.org/article/1f12fb48fd904cf39baf8413deebcf03
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
ABSTRACTWith the widespread vaccination of COVID-19 vaccine, a few cases have been reported that COVID-19 vaccine may cause endocrine disorders. A 59-y-old man presented with a loss of appetite after the first COVID-19 vaccination, which resolved spo
Externí odkaz:
https://doaj.org/article/1214b95602c44b5b8d9078bfeaff4831
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
With advancements in medical oncology, immune checkpoint inhibitors (ICIs) have become the first-line treatment for many malignancies. ICIs play a significant role in improving cancer prognosis, but a series of immune-related adverse events (irAEs),
Externí odkaz:
https://doaj.org/article/65ae2540a2b54537b32f7f4611f34cf6
Autor:
Lingfeng Yu, Gentao Fan, Qingyan Wang, Yan Zhu, Hao Zhu, Jiang Chang, Zhen Wang, Shoubin Zhan, Xianming Hua, Diankun She, Jianhao Huang, Yicun Wang, Jianning Zhao, Chen-Yu Zhang, Xi Chen, Guangxin Zhou
Publikováno v:
Cell Death and Disease, Vol 14, Iss 9, Pp 1-16 (2023)
Abstract The prognosis of lung metastatic osteosarcoma (OS) remains disappointing. siRNA-based gene silencing of VEGFR2 is a promising treatment strategy for lung metastatic OS, but there is a lack of safe and efficient delivery systems to encapsulat
Externí odkaz:
https://doaj.org/article/a0b64b83e94e4269b8745c8684054d39
Autor:
Lingfeng Yu, Hao Zhu, Zhen Wang, Jianhao Huang, Yan Zhu, Gentao Fan, Yicun Wang, Xi Chen, Guangxin Zhou
Publikováno v:
Molecular Cancer, Vol 21, Iss 1, Pp 1-20 (2022)
Abstract Background Disappointing clinical efficacy of standard treatment has been proven in refractory metastatic osteosarcoma, and the emerging anti-angiogenic regimens are still in the infantile stage. Thus, there is an urgent need to develop nove
Externí odkaz:
https://doaj.org/article/bfbfb860921844568c61249ca59c6d04
Autor:
Zhen Wang, Yanting Wei, Hao Zhu, Lingfeng Yu, Jie Zhu, Qixiu Han, Ziying Liu, Jianhao Huang, Yan Zhu, Gentao Fan, Qikai Tang, Ji Qian, Xi Chen, Guangxin Zhou
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-15 (2022)
Abstract Background Osteosarcoma (OS) is the most common primary malignant bone tumors in children and adolescents. Large numbers of studies have focused on the long non-coding RNA (lncRNA) that plays essential roles in the progression of osteosarcom
Externí odkaz:
https://doaj.org/article/f0ec53b690e74ac480accbb1af3c3276
Autor:
Zhen Wang, Yanting Wei, Hao Zhu, Lingfeng Yu, Jie Zhu, Qixiu Han, Ziying Liu, Jianhao Huang, Yan Zhu, Gentao Fan, Qikai Tang, Ji Qian, Xi Chen, Guangxin Zhou
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-1 (2023)
Externí odkaz:
https://doaj.org/article/8f6033ffcc394315bb2abba3e40496d2
Autor:
Jianhao Huang, Jingwei Lu, Ziying Liu, Jing Jin, Chunmei Xie, Yang Zheng, Zhen Wang, Lingfeng Yu, Yan Zhu, Gentao Fan, Guojing Sun, Zhihong Xu, Guangxin Zhou
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 10 (2022)
Objective: Promoting bone regeneration and repairing in bone defects is of great significance in clinical work. Using a simple and effective surface treatment method to enhance the osteogenic ability of existing bone scaffold is a promising method. I
Externí odkaz:
https://doaj.org/article/d4265646611049d589741a6cd34b0b44
Autor:
Zhen Wang, Gentao Fan, Hao Zhu, Lingfeng Yu, Diankun She, Yanting Wei, Jianhao Huang, Tianhang Li, Shoubin Zhan, Shenkai Zhou, Yan Zhu, Yicun Wang, Xi Chen, Jianning Zhao, Guangxin Zhou
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundOsteosarcoma (OS) is the most common primary malignant bone tumors in children and adolescents. Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 (PLOD2) is a key gene in mediating the formation of the stabilized collagen cross-link, playi
Externí odkaz:
https://doaj.org/article/228b6cc3f8da4bc3b80f829f4559da9f
Publikováno v:
Iranian Journal of Immunology; Sep2024, Vol. 21 Issue 3, p255-260, 6p